Datura metel L. has been frequently used in Chinese traditional medicine. However, little is known on the chemical composition and in vivo metabolism of its seeds. In this study, using the strategy "chemical analysis, metabolism of single representative compounds, and metabolism of extract at clinical dosage" that we propose here, 42 constituents were characterized from D. metel seeds water extract. Furthermore, the metabolic pathways of 13 representative bioactive compounds of D. metel seeds were studied in rats after the oral administration of D. metel seeds water extract at a clinical dosage (0.15 g/kg). These included three withanolides, two withanolide glucosides, four amides, one indole, one triterpenoid, one steroid, and one sesquiterpenoid, and with regard to phase II metabolism, hydroxylation, (de)methylation, and dehydrogenation reactions were dominant. Furthermore, the metabolism of D. metel seeds water extract provided to rats at a clinical dosage was investigated by liquid chromatography-tandem mass spectrometry based on the above metabolic pathways. Sixty-one compounds were detected in plasma, 83 in urine, and 76 in fecal samples. Among them, withanolides exhibited higher plasma exposure than the other types. To our knowledge, this is the first systematic study on the chemical profiling and metabolite identification of D. metel seeds, including all compounds instead of single constituents.
INTRODUCTION
Datura metel L. (Solanaceae) seeds are one of the most popular herbal medicines for the treatment of rheumatoid arthritis and convulsions (Murthy et al., 2004) . Although the seeds are toxic, they also have strong analgesic, anthelmintic, antioxidant, antimicrobial, antiviral, and antidiabetic activities (Wannang and Ndukwe, 2009; Kamaraj et al., 2011; Gu et al., 2014; Bachheti et al., 2018; Roy et al., 2018) . Withanolides, flavonoids, alkaloids, sesquiterpenoids, lignans, and phenolic acids are generally considered the major bioactive compounds of D. metel (Kuang et al., 2008; Mai et al., 2017) . However, there are few reports on the chemical composition of D. metel seeds. In previous studies, amides, indoles, sesquiterpenes, withanolides, and withanolide glucosides have been isolated from D. metel (Yang et al., 2010a,b; Bellila et al., 2011) , but the constituents responsible for the treatment of different conditions have not been clarified.
It is well known that the in vivo metabolites of herbal medicines may play a substantial role in the therapeutics. Therefore, metabolites' identification is critical for elucidating the bioactivities of complex herbal medicines. Recently, we studied the metabolism of two typological components, including two amides (n-trans-feruloyltyramine and cannabisin F) and two withanolide glucosides (daturataturin A and daturametelin I) of D. metel seeds in rats (Xu et al., 2018) . To fully predict and identify their metabolites, we selected seven main types of representative compounds from the seeds.
In this study, we aimed to improve this strategy so that it can be applied to other herbal medicines. Focusing on the identification of the in vivo metabolites of D. metel seed extracts after oral administration in rats, we first established the chemical fingerprint of D. metel seeds and identified 42 seed components (Figure 1) . Second, we examined the in vivo metabolic pathways of seven groups of metabolites with different scaffolds, which included 13 representative compounds, using quadrupole time-of-flight mass spectrometry (qTOF-MS) and liquid chromatography-tandem mass spectrometry (LC/MS/MS). Finally, a normal clinical dosage of the herbal extract was administered to rats, and several metabolites were detected based on the metabolic pathways. Following this strategy, 113 metabolites (including 42 original phytochemicals and 71 newly formed ones) were detected at a clinical dosage (0.15 g/kg) in rats.
MATERIALS AND METHODS

Chemicals and Reagents
The pure compounds daturametelindole B (1), daturametelin M (3), hyoscyamilactol (5), daturametelindole A (9), daturametelin L (29), daturametelindole D (18), n-trans-feruloyltyramine (19), daturametelindole C (22), daturametelin I (30), cannabisin F (31), daturaolone (32), daturataturin A (36), n-trans-p-coumaroyltyramine (40), and stigmasterol (41) were isolated from the seeds of D. metel by the authors. Their structures were characterized using nuclear magnetic resonance and MS (Figure 2 and Supplementary Figures S3-S22 ; FIGURE 1 | The three-step strategy proposed in the present study. Xu et al., 2018) . Dinoxin B (10), withametelin L (13), and cinerolide (20) were purchased from Nantong Feiyu Biological Technology Co., Ltd. (Nanjing, China). Purities were above 98% according to high-performance liquid chromatography-ultraviolet (HPLC/UV) analysis. Betaglucuronidase (HP-2 type, containing 100,000 U β-glucuronidase and 7500 U sulfatase per milliliter), β-nicotinamide adenine dinucleotide phosphate hydrate (β-NADP), D-glucose 6-phosphate sodium salt (G-6-P), and glucose-6-phosphate dehydrogenase (G-6-P-DE) used in the present study were purchased from Sigma-Aldrich (St. Louis, MO, United States). Heparin was purchased from HuiShi Biochemical Reagent Co., Ltd. (Shanghai, China). De-ionized water was prepared by a Milli-Q system (Millipore, Burlington, MA, United States). Acetonitrile, methanol, and formic acid (Sigma-Aldrich) were of HPLC grade. Other reagents were of analytical grade.
Preparation of the Water Decoction of Datura metel Seeds (WDS)
Datura metel seeds were collected from the medicinal botanical garden of Heilongjiang University of Traditional Chinese Medicine. The authenticity of the sample was identified by Dr. Ruifeng Fan, Botanist, Department of Medicinal Plant, Heilongjiang University of Traditional Chinese Medicine. The voucher specimen (specimen number: 2016035) were preserved in the laboratory of Chinese Medicine Chemistry, Heilongjiang University of Traditional Chinese Medicine. The WDS was prepared by extracting 100 g of D. metel seeds decocted in 600 mL water three times (2.0, 2.0, 1.0 h). The decoctions were combined, filtered, and concentrated in vacuum at 50 • C. The final concentration of the extract was 0.01 g/mL (crude drug per g/mL).
Animals and Drug Administration
Male Sprague-Dawley rats (180-220 g) were purchased from the Laboratory Animal Center of the Second Affiliated Hospital of Harbin Medical University (Heilongjiang Province, China). The rats were kept in metabolic cages (465 mm × 300 mm × 200 mm), and the breeding room was at 25 • C and 60 ± 5% relative humidity. All animals had free access to water and normal chow was provided ad libitum at a 12 h dark-light cycle for 3 days, and then fasted for 12 h before the experiments. The animal facilities and protocols were approved by the Animal Care and Use Committee of the Harbin Medical University. All procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (ILAR, 1996) .
The pure compounds, including 1, 3, 5, 9, 10, 13, 18, 20, 22, 29, 32, 40, and 41, were suspended in 1% carboxy-methyl cellulose-sodium and were separately provided to rats (n = 4) orally at 20 mg/kg. The WDS was provided to rats (n = 4) at 0.5 g/kg (clinical dosage, equivalent to 600 mg/day for a 60-kg human), respectively. The dosage in our study was the clinically safe and effective (Pharmacopoeia Commission, 2015) . The control group (n = 4) was administrated with 1000 µL normal saline.
Preparation of Plasma, Urine, and Fecal Samples
To obtain plasma samples, blood (1000 µL) was collected from the angular vein into heparinized tubes at six time points: 0.5, 1, 2, 4, 6, and 10 h after the administration of WDS and pure compounds (n = 4). The blood of two rats was collected at 0.5, 2, and 6 h, or at 1, 4, and 10 h, and then centrifuged at 10,000 × g for 10 min at 4 • C to obtain the plasma and then pooled plasma samples of different time points. Urine and fecal samples were collected for 0-24 h from rats held in metabolic cages (DXL-D, Keke Medical Model Co., Ltd., Shanghai, China).
Plasma, urine, and fecal samples were prepared as described in our previous report (Xu et al., 2018) . The residue of these samples was dissolved in 300 µL of methanol, and filtered through a 0.22-µm membrane for ultra-high performance liquid chromatography coupled with electrospray ionization (UPLC/ESI) qTOF-MS analysis.
Incubation of Rat Liver Microsomes
Compounds 3, 5, 10, 13, 29, 40, and 41 were separately dissolved in methanol, and then diluted with phosphate buffered saline (PBS). The final concentration of each compound in the 200-µL incubation mixture (NADPH-generating system, 100 mM potassium phosphate buffer (pH 7.4), and rat liver microsomes) was 25 µM, and the amount of organic solvent in the mixture was lower than 1% (v/v). PBS-containing methanol was added as the negative control. The incubation was conducted at 37 • C for 2 h. After this period, the reaction was terminated by adding 1000 µL of cold acetonitrile. The mixture was then kept at 4 • C for 30 min, and the precipitated protein was removed by centrifugation at 10,000 × g for 10 min at 4 • C.
Enzyme Hydrolysis
A 100-µL aliquot of plasma or urine sample was dried under a gentle flow of nitrogen gas and then mixed with 400 µL of b-glucuronidase solution (containing 19.86 U/µL, in sodium acetate buffer, pH 5.5). The mixture was vortexed for 5 min, incubated in a 37 • C water bath for 1.5 h, treated with 1000 µL of cold methanol-acetonitrile (1:1, v/v) to precipitate the protein, and then centrifuged at 10,000 × g for 10 min at 4 • C. The supernatant was dried under a gentle nitrogen flow and then dissolved in 100 µL of methanol. The solution was filtered through a 0.22-µm membrane for analysis.
UPLC/ESI/qTOF-MS Analysis
The analysis was performed on an ACQUITY UPLC instrument coupled with a Xevo G2 qTOF mass spectrometer (Waters, Milford, MA, United States) via an ESI ion source. The autosampler was controlled via the MassLynx TM 4.1 software (Waters). Samples were separated on an ACQUITY UPLC HSS T3 column (2.1 mm × 100 mm, 1.7 µm; Waters). The mobile phase consisted of acetonitrile (A) and water containing 0.1% (v/v) formic acid (B) at a flow rate of 400 µL/min. The gradient elution program was set as follows: 0-7 min, 10-22% A; 7-13 min, 22-70% A; 13-17 min, 70-90% A; 17-20 min, 90-95% A; 20-22 min, 95% A. A 2-µL sample aliquot was injected for analysis, and the column temperature was 40 • C.
The qTOF/MS system was equipped with an ESI source operating in positive ion mode, as in our previous report (Xu et al., 2018) . High-purity nitrogen (N 2 ) and high-purity helium (He) were used as desolvation gas and collision gas, respectively. The flow rate of N 2 was 600 L/h and that of He was 50 L/h. The optimized parameters were: capillary voltage, 3.5 kV; sample cone voltage, 30 V; and extraction cone voltage, 4 V. The desolvation and source temperatures were 350 • C and 100 • C, respectively. The MS full scan range was 100-1000 m/z, and MS n range was 100-800 m/z. All data collected in the positive ion mode were acquired and processed by the MassLynx TM 4.1 software (Waters). UHPLC/qTOF-MS is the high-resolution mass spectra, which could provide the accurate [M+H] + ions of the metabolites.
Quadrupole Ion Trap (Q TRAP) LC/MS/MS
The AB SCIEX 4000 Q TRAP TM composite triple quadrupole/linear ion trap tandem mass spectrometer (SCIEX, Framingham, MA, United States) connected to the UHPLC via the ESI interface (Applied Biosystems, Foster City, CA, United States) was operated in the positive ion mode. The column effluent was split using a zerodead-volume "T" connector, with approximately half of the flow being fed to the mass spectrometer. The interface and parameters of the mass spectrometer were as follows: spray capillary voltage, 5.5 kV; DP, 70 V; EP, 0 V; CE, 45 V; nebulizer pressure, 40 psi; dry gas pressure, 40 psi; curtain gas pressure, 10 psi; and dry gas temperature, 600 • C. All data were acquired and processed using Analyst (SCIEX). The mass spectrum fragment ions of MS 2 and MS 3 could be obtained by Q-TRAP LC/MS/MS.
RESULTS AND DISCUSSION
Characterization of the Chemical Constituents of WDS
A rapid and sensitive UHPLC/qTOF-MS method was employed to characterize the chemical constituents of WDS. Forty-two compounds (1-42) were identified or tentatively characterized (Figure 3) 
Metabolic Pathways of Single Representative Compounds
The chemical constituents of WDS were classified into seven groups according to their structural type: withanolides (A), withanolide glucosides (B), amides (C), indoles (D), triterpenoids (E), steroids (F), and sesquiterpenoids (G). In our previous study, we selected four representative compounds containing two withanolide glucosides (daturataturin A and daturametelin I), and two amides (cannabisin F and n-trans-feruloyltyramine) from WDS and elucidated their metabolic pathways (Xu et al., 2018) . In the present study, we used these pathways for metabolite identification of other compounds, which had similar scaffolds in WDS, developing a "compound to extract" strategy. (41) were first reported in this study, and these 13 single compounds were selected to represent seven major scaffolds in WDS. These compounds were labeled in the HPLC fingerprint of WDS. As shown in Table 1 , the multistage mass spectrum fragmentation information (ESI-MS n ) was obtained both from UPLC/ESI/qTOF-MS and Q TRAP LC/MS/MS analysis.
Withanolides
Compounds 3, 5, and 13 were chosen as representatives of withanolides (Figure 2 ). They were considered as bioactive constituents (Ma et al., 1999; Zhang et al., 2018) and could be detected per se in plasma and urine samples. Hydroxylation was the major metabolic reaction for withanolides from D. metel (Table 1 ). In addition, compounds 3 and 5 may be metabolized into 21-OH daturametelin M and 21-OH hyoscyamilactol, respectively. This reaction was also observed for daturataturin A (36) and daturametelin I (30) in our previous study (Xu et al., 2018) . However, the hydroxyl position of 13 could not be assigned due to the limited structural information. Hydroxylated products were also detected when 3, 5, and 13 were incubated in rat liver microsomes, indicating that the hydroxylation reaction was catalyzed by P450 enzymes (Supplementary Figure S1) .
Withanolide Glucosides
The metabolism of two withanolide glucosides, 10 and 29, was investigated. When O-glycosides lose the sugar residue to produce corresponding aglycones (withanolides), dehydrogenation occurs. This reaction of interconversion was very common for withanolide glucosides. In addition, hydroxylation, (de)methylation, and glucuronidation of withanolide glucosides were also major reactions as shown in Figures 4A,B . These metabolites, derived from the three withanolide glucosides, were detected in plasma, urine, and fecal samples ( Table 1) 
Amides
Amides are abundant in D. metel seeds, and considered as characteristic components (Karim et al., 2017) . Four major amides (1, 18, 22, and 40) were chosen to examine the in vivo metabolism of this type of compounds. In brief, the metabolism of amides varied significantly according to the group substitutions on their backbones. For example, 1 and 40 could undertake different phase I reactions, including hydroxylation, dehydrogenation, hydroxylation, and hydration. Phase II conjugation reactions (to form glucuronides and sulfates) were common in amides (Table 1) , but the peaks of glucuronides disappeared when the sample was treated with β-glucuronidase (Supplementary Figure S2) . Amides 18 and 22 were mainly involved in demethylation and sulfation. The major metabolic reactions and metabolite distributions of these four amides are listed in Table 1 . Plasma and urine samples mainly contained phase II metabolites and hydroxylated products, while urine samples comprised most metabolites.
Indoles
Indole alkaloids in D. metel seeds are extremely important, and their distribution and metabolism have been reported in several different organisms (Gillam et al., 2000; van der Fits and Memelink, 2000; Rischer et al., 2006; Ziegler and Facchini, 2008) . We chose daturametelindole A (9) for examining metabolic pathways. The qTOF mass spectra showed [M+H] + ions at m/z 243.1116, consistent with the molecular formula of C 14 H 14 N 2 O 2 . In the ion trap MS n spectra, the [M+H] + ions could further add a glucuronic acid moiety (176 U), and then be dehydrogenized, hydroxylated, and sulfated to produce the corresponding ions at m/z 417 (9-M1), 435 (9-M2), and 499 (9-M4), respectively ( Figure 4C) . The above conjugates were confirmed by enzyme hydrolysis. When indole 9 from the plasma sample was treated with β-glucuronidase, the peaks of 9-M1, 9-M2, and 9-M4 disappeared, and the peak corresponding to 9 increased remarkably ( Figure 4C) . Thus, it could be deduced that these metabolites were glucuronides of 9. The sulfate conjugates 9-M5 and 9-M6 were detected in plasma, urine, and fecal samples. Their MS/MS spectra were dominated by the neutral loss of 80 Da. Metabolite 9-M3 was highly abundant in fecal samples. Its high-resolution mass spectra Figure 4C .
Triterpenoids, Steroids, and Sesquiterpenoids
In addition to the major structural types (A) to (D), less abundant groups of compounds were also found in WDS in previous chemical studies (Kuang et al., 2009; Yang et al., 2014; Bhardwaj et al., 2016) . They were taken into consideration in this study, and the representative scaffolds included triterpenoids (32, daturaolone), steroids (41, stigmasterol), and sesquiterpenoids (20, cinerolide). Identification of 32, 41, and 20 is depicted in Table 1 . When 32 was provided to rats, high amounts of prototype were detected in fecal samples. The methoxyl groups at C-23, -14, -29, or -30 may undergo hydroxylation, followed by glucuronide conjugation ( Table 1 ; Sanchez-Gonzalez et al., 2015) . The phase I and phase II metabolites of 41 were also observed in vivo samples. Among phase I metabolites, the hydroxylation products were extensively observed. This type of reaction involved the addition of one or two hydroxyl groups to the parent drug. The phase II biotransformation was mainly sulfation, and the phase II metabolite 41-M3 was formed by a reduction reaction followed by a sulfated reaction. Most steroids were metabolized in the same way as ganoderic acid D (Cheng et al., 2012) . After 20 mg/kg oral administration, a large portion of 20 was metabolized. Although this compound was not observed in plasma samples, it occurred in the unchanged form in fecal samples. The UPLC/ESI/qTOF-MS analysis detected large proportions of three metabolites in plasma samples ( Table 1) 
